Wedbush Securities Inc V Tv Therapeutics Inc. Transaction History

Wedbush Securities Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.49 - $3.1 $32,780 - $68,200	-22,000 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$1.7 - $2.98 $2,380 - $4,172	1,400 Added 6.8%	22,000 $39,000
Q2 2020 Jul 16, 2020	BUY	$1.74 - $3.19 $10,440 - $19,140	6,000 Added 41.1%	20,600 $46,000
Q1 2020 Apr 17, 2020	BUY	$1.63 - $3.75 $23,798 - $54,750	14,600 New	14,600 $28,000
Q4 2019 Jan 16, 2020	SELL	$1.37 - $1.97 $34,387 - $49,447	-25,100 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$1.26 - $1.77 $31,626 - $44,427	25,100 New	25,100 $39,000
Q2 2019 Aug 01, 2019	SELL	$1.29 - $1.83 $22,575 - $32,025	-17,500 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$1.67 - $3.12 $29,225 - $54,600	17,500 New	17,500 $30,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.1B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.